- Home
- NXPI vs AFL Comparison
NXPI vs AFL Comparison
Compare NXPI & AFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXPI
- AFL
- Stock Information
- Founded
- NXPI 2006
- AFL 1955
- Country
- NXPI Netherlands
- AFL United States
- Employees
- NXPI N/A
- AFL N/A
- Industry
- NXPI Semiconductors
- AFL Accident &Health Insurance
- Sector
- NXPI Technology
- AFL Finance
- Exchange
- NXPI Nasdaq
- AFL Nasdaq
- Market Cap
- NXPI 60.0B
- AFL 57.0B
- IPO Year
- NXPI 2010
- AFL N/A
- Fundamental
- Price
- NXPI $236.52
- AFL $102.14
- Analyst Decision
- NXPI Strong Buy
- AFL Hold
- Analyst Count
- NXPI 19
- AFL 14
- Target Price
- NXPI $264.32
- AFL $102.93
- AVG Volume (30 Days)
- NXPI 3.4M
- AFL 1.9M
- Earning Date
- NXPI 02-03-2025
- AFL 02-05-2025
- Dividend Yield
- NXPI 1.72%
- AFL 2.27%
- EPS Growth
- NXPI N/A
- AFL 23.78
- EPS
- NXPI 9.73
- AFL 9.63
- Revenue
- NXPI $12,614,000,000.00
- AFL $18,927,000,000.00
- Revenue This Year
- NXPI N/A
- AFL N/A
- Revenue Next Year
- NXPI $10.35
- AFL $1.44
- P/E Ratio
- NXPI $24.31
- AFL $10.61
- Revenue Growth
- NXPI N/A
- AFL 1.21
- 52 Week Low
- NXPI $198.21
- AFL $78.62
- 52 Week High
- NXPI $296.08
- AFL $115.50
- Technical
- Relative Strength Index (RSI)
- NXPI 63.59
- AFL 40.25
- Support Level
- NXPI $207.64
- AFL $102.84
- Resistance Level
- NXPI $255.45
- AFL $104.78
- Average True Range (ATR)
- NXPI 8.98
- AFL 1.83
- MACD
- NXPI 3.47
- AFL -0.21
- Stochastic Oscillator
- NXPI 66.93
- AFL 9.67
About NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About AFL AFLAC Incorporated
Aflac Inc offers supplemental health insurance and life insurance in United States and Japan. In addition to its cancer policies, the company has broadened its product offerings to include accident, dental and vision, disability, and long-term-care insurance. It markets its products through independent distributors, selling majority of its policies directly to consumers at their places of work and also reaches out to its customers out of their worksite through digital mediums. The company has two reportable business segments; Aflac Japan which generates the majority of the revenue, and Aflac U.S.